Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161 Provided by GlobeNewswire May 19, 2025, 12:25:00 PM.

Study represents the first clinical application of CMND-100, the Company’s proprietary drug platform . Vancouver, Canada, March 18, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND ...

Vasa Therapeutics Announces Initiation of Phase 1 First-in-Human Clinical Trial of VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction. News provided by.

First patient enrolled in Phase I/IIa clinical trial for Lenti-HPV-07, the TheraVectys vaccine candidate against oropharyngeal and cervical cancers.

Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.

Nimbus Therapeutics Announces Initiation of First-in-Human Clinical Trial with NDI-219216, Novel WRN Inhibitor for MSI-H Tumors. ... The Phase 1/2 clinical trial (NCT06898450) ...